Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBDENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CN.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.576ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.325ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.521ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.378ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.206ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.13.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBEENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.10.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.23.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.64ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.68ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.65 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.466ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
L.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used